Fupin S. Hu

12 Middle Wulumuqi Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

Erratum for Meng et al., "Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant Enterobacterales".

Erratum for Meng et al., "Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant Enterobacterales".

Journal: Microbiology spectrum

Published: August 25, 2026

Veterinary-specific breakpoints for ceftiofur applicable to canine Escherichia coli.

Veterinary-specific breakpoints for ceftiofur applicable to canine Escherichia coli.

Journal: Journal of clinical microbiology

Published: July 27, 2026

In vitro activity of aztreonam-avibactam and comparators against Enterobacterales isolated from bloodstream infections: ATLAS/ surveillance, 2021-2022.

In vitro activity of aztreonam-avibactam and comparators against Enterobacterales isolated from bloodstream infections: ATLAS/ surveillance, 2021-2022.

Journal: Microbiology spectrum

Published: June 30, 2026

Emergence of tmexCD1-toprJ1 in the clinical high-risk clone sequence type 147 among carbapenem-resistant Klebsiella pneumoniae isolates in China: A multicentre retrospective study.

Emergence of tmexCD1-toprJ1 in the clinical high-risk clone sequence type 147 among carbapenem-resistant Klebsiella pneumoniae isolates in China: A multicentre retrospective study.

Journal: Virulence

Published: April 02, 2026

In Vitro Activity of Cefiderocol Against Clinically Relevant Gram-Negative Bacilli Collected in China in 2023.

In Vitro Activity of Cefiderocol Against Clinically Relevant Gram-Negative Bacilli Collected in China in 2023.

Journal: Journal of global antimicrobial resistance

Published: March 21, 2026

Mechanisms underlying altered ceftazidime-avibactam resistance in Klebsiella pneumoniae driven by KPC-234 mutation and IncX3-NDM-1 plasmid transfer.

Mechanisms underlying altered ceftazidime-avibactam resistance in Klebsiella pneumoniae driven by KPC-234 mutation and IncX3-NDM-1 plasmid transfer.

Journal: International journal of antimicrobial agents

Published: March 17, 2026

Cefiderocol susceptibility rates in carbapenem-resistant Gram-negative bacteria in a comparative, multicenter surveillance study in China.

Cefiderocol susceptibility rates in carbapenem-resistant Gram-negative bacteria in a comparative, multicenter surveillance study in China.

Journal: International journal of antimicrobial agents

Published: March 16, 2026

Within-host co-evolution of KPC variants: plasmid-mediated dissemination of blaKpc-194 and blaKpc-33 in ST11-KL64 hypervirulent Klebsiella pneumoniae driving ceftazidime-avibactam resistance.

Within-host co-evolution of KPC variants: plasmid-mediated dissemination of blaKpc-194 and blaKpc-33 in ST11-KL64 hypervirulent Klebsiella pneumoniae driving ceftazidime-avibactam resistance.

Journal: Microbiology spectrum

Published: March 16, 2026

Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024.

Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024.

Journal: The Journal of infectious diseases

Published: March 13, 2026

Suboptimal ceftazidime-avibactam exposure drives sequential blaKPC mutations and intra-host coexistence of Klebsiella pneumoniae harboring distinct variants leading to persistent infection.

Suboptimal ceftazidime-avibactam exposure drives sequential blaKPC mutations and intra-host coexistence of Klebsiella pneumoniae harboring distinct variants leading to persistent infection.

Journal: Microbiology spectrum

Published: February 20, 2026

Assessment of the revision of the 2025 CLSI breakpoints for the interpretation of minocycline susceptibility for Acinetobacter baumannii complex.

Assessment of the revision of the 2025 CLSI breakpoints for the interpretation of minocycline susceptibility for Acinetobacter baumannii complex.

Journal: Microbiology spectrum

Published: February 13, 2026

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant Enterobacterales.

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant Enterobacterales.

Journal: Microbiology spectrum

Published: January 30, 2026

Showing 1-12 of 194

Last Updated: 09/26/2026